CX-1942 je agonist AMPA receptora.[3][4][5]

CX-1942
[4-[2,1,3-benzoksadiazol-5-karbonil(metil)amino]cikloheksil] 2-aminoacetat
Nazivi
IUPAC naziv
[4-[2,1,3-benzoksadiazol-5-karbonil(metil)amino]cikloheksil] 2-aminoacetat
Drugi nazivi
  • SID 397224906
  • FELKWJSNCYNOKB-HAQNSBGRSA-N
Identifikacija
3D model (Jmol)
  • CN([C@@H]1CC[C@H](CC1)OC(=O)CN)C(=O)c2ccc3nonc3c2
Svojstva
C16H20N4O4
Molarna masa 332,36 g·mol−1
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
Reference infokutije

Reference

уреди
  1. ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.  уреди
  2. ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1. 
  3. ^ D. E. Jane; H. W. Tse; D. A. Skifter; J. M. Christie; D. T. Monaghan. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Glutamate Receptor Ion Channels: Activators and Inhibitors. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Springer. стр. 415—478. 
  4. ^ „Clinical methods and pharmaceutical compositions employing ampa receptor antagonists to treat glioblastoma and other cancers”. 
  5. ^ Di-substituted amides for enhancing glutamatergic synaptic responses